Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide-Reference-Cited by-同舟云学术

Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide

Published:2004-02 Issue:2 Volume:23 Page:197-199
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Jones Ronald N,Streit Jennifer M,Fritsche Thomas R

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference14 articles.

1. Dalbavancin: phase II demonstration of efficacy of a novel, weekly dosing regimen in skin and soft tissue infection (Abstract O143);Seltzer;Clin. Microbiol. Infect. Dis.,2003

2. In vitro and in vivo antibacterial activity of BI397, a new semi-synthetic glycopeptide antibiotic;Candiani;J. Antimicrob. Chemother.,1999

3. Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic;Goldstein;Antimicrob. Agents Chemother.,1995

4. In vitro evaluation of BI397, a novel glycopeptide antimicrobial agent;Jones;J. Chemother.,2001

5. Malabarba A, Ciabatti R, Romano G, Ripamonti F, Candlani G, Abbondi M. F. BI397: a new developmental semisynthetic glycopeptide antibiotic (Abstract F-107). In: Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego (CA); 1998.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides;Antimicrobial Agents and Chemotherapy;2022-06-21

2. Reproducibility of dalbavancin MIC test results and an updated surrogate accuracy analysis of vancomycin MIC values to infer dalbavancin susceptibility (2014);Diagnostic Microbiology and Infectious Disease;2016-10

3. Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014);Antimicrobial Agents and Chemotherapy;2016-06

4. Telavancin Demonstrates Activity against Methicillin-Resistant Staphylococcus aureus Isolates with Reduced Susceptibility to Vancomycin, Daptomycin, and Linezolid in Broth Microdilution MIC and One-Compartment Pharmacokinetic/Pharmacodynamic Models;Antimicrobial Agents and Chemotherapy;2015-06-29

5. Validation of Sensititre Dry-Form Broth Microdilution Panels for Susceptibility Testing of Ceftazidime-Avibactam, a Broad-Spectrum-β-Lactamase Inhibitor Combination;Antimicrobial Agents and Chemotherapy;2015-05-26